aTyr Pharma | LIFE - Trade Debtors


aTyr Pharma reported $296.74M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Alterity Therapeutics Limited AUD 8.67M 1.59M Jun/2023
Ardelyx USD 71.85M 4.76M Dec/2025
aTyr Pharma USD 296.74M 295.7M Dec/2025
Biogen USD 1.85B 234M Sep/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Cipla INR 74.61B 19.39B Sep/2025
Clal Biotechnology ILS 3.75M 186K Dec/2022
Compugen USD 2.38M 448K Dec/2025
CSL USD 4.32B 1.35B Dec/2025
Curis USD 2.55M 400K Jun/2024
Galapagos EUR 199.75M 122.08M Dec/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
Grifols EUR 1B 285.88M Dec/2025
Novartis USD 12.29B 3.3B Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
United Therapeutics USD 350.2M 52.5M Dec/2025
Xoma USD 14.78M 4.96M Jun/2024